AKT1 and liver cancer: The current study is the first to provide direct evidence that by interacting with hnRNPA2B1, TSA-induced uc002mbe.2 deactivates AKT, increases p21 and has a cytostatic effect in human liver cancer cells in vitro and in vivo.